Ventures Iii Lp Aberdare, 10% Owner at Conatus Pharmaceuticals Inc (CNAT), bought 2,172,730 shares at $11.00 ($1.3M) on 2013-07-30, disclosed to the SEC on 2013-08-01.
Open-market purchase of $1.3M CNAT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,979,321 | $0 | 0.0% |
| 2 | $0.08 | 1,727 | $138 | 0.0% |
| 3 | $0.08 | 73,395 | $6K | 0.4% |
| 4 | $11.00 | 251 | $3K | 0.2% |
| 5 | $11.00 | 2,470 | $27K | 2.1% |
| 6 | $11.00 | 10,614 |
| $117K |
| 8.9% |
| 7 | $11.00 | 104,952 | $1.2M | 88.3% |
| Total | $0.60 avg | 2,172,730 | $1.3M | 100% |